Discovery of 9,11-Seco-Cholesterol Derivatives as Novel FXR Antagonists

被引：5
|
作者：
Zhou, Jia-Xu [1 ,2 ]
Li, Cui-Na [2 ]
Liu, Ya-Meng [2 ]
Lin, Su-Qin [3 ]
Wang, Ying [2 ]
Xie, Cen [2 ]
Nan, Fa-Jun [1 ,2 ,4 ]
机构：
[1] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China
[3] Nanjing Univ Chinese Med, Sch Chinese Mat Med, Nanjing 210046, Peoples R China
[4] Bohai Rim Adv Res Inst Drug Discovery, Drug Discovery Shandong Lab, Yantai 264117, Shandong, Peoples R China
来源：
ACS OMEGA | 2022年 / 7卷 / 20期
基金：
中国国家自然科学基金;
关键词：
FARNESOID-X-RECEPTOR; NUCLEAR RECEPTOR; BILE-ACIDS; POTENT;
D O I：
10.1021/acsomega.2c01567
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
The farnesoid X receptor (FXR) plays an important role in the regulation of bile acid, lipid, and glucose homeostasis. Recent findings have shown that the inhibition of FXR is beneficial to improvement of related metabolic diseases and cholestasis. In the present work, 9,11-seco-cholesterol derivatives were designed and synthesized by cleaving the C ring of cholesterol and were identified as novel structures of FXR antagonists. Compound 9a displayed the best FXR antagonistic activity at the cellular level (IC50 = 4.6 mu M) and decreased the expression of the target genes of FXR in vivo.
引用
收藏
页码：17401 / 17405
页数：5
相关论文
共 50 条
  • [41] Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F-2 alpha
    Krauss, AHP
    Woodward, DF
    Gibson, LL
    Protzman, CE
    Williams, LS
    Burk, RM
    Gac, TS
    Roof, MB
    Abbas, F
    Marshall, K
    Senior, J
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 117 (06) : 1171 - 1180
  • [42] Discovery of KRP-199: Synthesis of novel quinoxalinecarboxylic acid derivatives as highly potent and selective AMPA receptor antagonists.
    Takano, Y
    Shiga, F
    Asano, K
    Uchiki, H
    Hori, W
    Fukuchi, K
    Anraku, T
    Uno, T
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : A95 - A95
  • [43] Discovery of novel spiro-piperidine derivatives as highly potent and selective melanin-concentrating hormone 1 receptor antagonists
    Suzuki, Takao
    Moriya, Minoru
    Sakamoto, Toshihiro
    Suga, Takuya
    Kishino, Hiroyuki
    Takahashi, Hidekazu
    Ishikawa, Makoto
    Nagai, Keita
    Imai, Yumiko
    Sekino, Etsuko
    Ito, Masahiko
    Iwaasa, Hisashi
    Ishihara, Akane
    Tokita, Shigeru
    Kanatani, Akio
    Sato, Nagaaki
    Fukami, Takehiro
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (11) : 3072 - 3077
  • [44] Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (part 2)
    Peretto, Ilaria
    Fossati, Claudia
    Giardina, Giuseppe A. M.
    Giardini, Alessandra
    Guala, Matilde
    La Porta, Elena
    Petrillo, Paola
    Radaelli, Stefano
    Radice, Luigi
    Raveglia, Luca F.
    Santoro, Enza
    Scudellaro, Roberta
    Scarpitta, Francesca
    Cerri, Alberto
    Menegon, Sergio
    Dondio, Giulio M.
    Rizzi, Andrea
    Armani, Elisabetta
    Amari, Gabriele
    Civelli, Maurizio
    Villetti, Gino
    Patacchini, Riccardo
    Bergamaschi, Marco
    Bassani, Franco
    Delcanale, Maurizio
    Imbimbo, Bruno P.
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (07) : 1693 - 1697
  • [45] Discovery of novel 9H-purin derivatives as dual inhibitors of HDAC1 and CDK2
    Yu, Yu
    Ran, Dongzhi
    Jiang, Junhao
    Pan, Tao
    Dan, Yanrong
    Tang, Qiang
    Li, Wei
    Zhang, Lin
    Gan, LinLing
    Gan, Zongjie
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (16) : 2136 - 2140
  • [46] Discovery of Novel Pyrazolopyrimidinone Derivatives as Phosphodiesterase 9A Inhibitors Capable of Inhibiting Butyrylcholinesterase for Treatment of Alzheimer's Disease
    Yu, Yan-Fa
    Huang, Ya-Dan
    Zhang, Chen
    Wu, Xu-Nian
    Zhou, Qian
    Wu, Deyan
    Wu, Yinuo
    Luo, Hai-Bin
    ACS CHEMICAL NEUROSCIENCE, 2017, 8 (11): : 2522 - 2534
  • [47] Discovery of quinazoline-benzothiazole derivatives as novel potent protease-activated receptor 4 antagonists with improved pharmacokinetics and low bleeding liability
    Li, Shanshan
    Liu, Shangde
    Yuan, Duo
    Liu, Renjie
    Hu, Lifang
    Zhu, Xiong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 280
  • [48] Discovery of 5-methyl-1H-benzo[d]imidazole derivatives as novel P2X3 Receptor antagonists
    Bae, Jinsu
    Kang, Koon Mook
    Kim, Yong-Chul
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 72
  • [49] Discovery of 2-aryloxy-4-amino-quinazoline derivatives as novel protease-activated receptor 2 (PAR2) antagonists
    Cho, Nam-Chul
    Cha, Ji Hyoun
    Kim, Hyojin
    Kwak, Jinsook
    Kim, Dohee
    Seo, Seung-Hwan
    Shin, Ji-Sun
    Kim, TaeHun
    Park, Ki Duk
    Lee, Jiyoun
    No, Kyoung Tai
    Kim, Yun Kyung
    Lee, Kyung-Tae
    Pae, Ae Nim
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (24) : 7717 - 7727
  • [50] Discovery of N-(4-(Benzyloxy)-phenyl)-sulfonamide Derivatives as Novel Antagonists of the Human Androgen Receptor Targeting the Activation Function 2
    Chai, Xin
    Sun, Huiyong
    Zhou, Wenfang
    Chen, Changwei
    Shan, Luhu
    Yang, Yuhui
    He, Junzhao
    Pang, Jinping
    Yang, Liu
    Wang, Xinyue
    Cui, Sunliang
    Fu, Yaqin
    Xu, Xiaohong
    Xu, Lei
    Yao, Xiaojun
    Li, Dan
    Hou, Tingjun
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (03) : 2507 - 2521
12345